Sirnaomics Ltd. announces that with effect from May 31, 2024 Dr. Francois Lebel has resigned from the position as the Chief Medical Officer of the Group to devote more time to his other commitments. Dr. Lebel has agreed to serve as a senior consultant for strategic drug development matters for the Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 HKD | -2.11% |
|
-13.41% | -87.01% |
06-03 | Sirnaomics Medical, Finance Chiefs Step Down | MT |
06-03 | Sirnaomics Ltd. Announces Resignation of Francois Lebel as the Chief Medical Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-87.01% | 52.59M | |
+16.73% | 123B | |
+21.13% | 115B | |
+18.05% | 25.85B | |
-17.94% | 20.9B | |
-16.24% | 16.52B | |
-11.76% | 16.77B | |
-44.45% | 15.56B | |
+69.92% | 15.49B | |
+1.41% | 13.45B |
- Stock Market
- Equities
- 2257 Stock
- News Sirnaomics Ltd.
- Sirnaomics Ltd. Announces Resignation of Francois Lebel as the Chief Medical Officer